Volume 26, Number 1—January 2020
CME ACTIVITY - Research
Paid Leave and Access to Telework as Work Attendance Determinants during Acute Respiratory Illness, United States, 2017–2018
Table 3
Characteristic | Total days worked, n = 1,306 | Days worked at the usual workplace, n = 1,306 |
---|---|---|
Access to telework | ||
No | Referent | Referent |
Yes |
1.25 (1.07–1.46)† |
0.98 (0.82–1.17) |
Access to paid leave | ||
No | Referent | Referent |
Yes |
0.81 (0.68–0.96)‡ |
0.81 (0.67–0.96)‡ |
Discouraged from coming to work with influenza-like symptoms | ||
Not agree | Referent | Referent |
Agree | 0.86 (0.76–0.97)‡ | 0.85 (0.74–0.96)‡ |
*Values are adjusted ratios of days worked (95% CI). Boldface indicates statistical significance. Total days worked represents the sum of days worked at the usual workplace and days teleworked during the first 3 days of illness. The dependent variable in the zero-inflated Poisson regressions was days worked during the first 3 days of illness (i.e., 0, 1, 2, or 3 d). The final models contained the following independent variables: access to telework; access to paid leave; employees are discouraged from coming to work when they have flulike symptoms; age; sex; education; fever; worked the day before illness; having a lot of control over taking days off for illnesses; full-time worker; and employee type. The variable “employees are encouraged to go home if they have influenza-like symptoms at work” was excluded from the models because it was highly correlated with the variable “employees are discouraged from coming to work when they have influenza-like symptoms” (Spearman correlation coefficient 0.76; p<0.001); the latter variable has more relevance for reducing virus transmission in the workplace (not coming to work at all vs. coming to work with influenza-like symptoms and then told to go home). Sixty-eight records were excluded because of missing values.
†p<0.01.
‡p<0.05.
1Preliminary results from this study were presented at the International Conference on Emerging Infectious Diseases, August 27–29, 2018, Atlanta, Georgia, USA.